{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T07:55:06Z","timestamp":1783238106798,"version":"3.54.6"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jaci.2021.10.010","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T18:49:07Z","timestamp":1634842147000},"page":"1442-1450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inborn errors of immunity: Recent progress"],"prefix":"10.1016","volume":"148","author":[{"given":"Neha","family":"Seth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Tuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.10.010_bib1","doi-asserted-by":"crossref","unstructured":"Thalhammer J, Kindle G, Nieters A, Rusch S, Sepp\u00e4nen MRJ, Fischer A, et\u00a0al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations [published online ahead of print April 23, 2021]. European Society for Immunodeficiencies Registry Working Party. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.015.","DOI":"10.1016\/j.jaci.2021.04.015"},{"key":"10.1016\/j.jaci.2021.10.010_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2300","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017","volume":"143","author":"Amatuni","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2021.10.010_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2018.08.027","article-title":"The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)","volume":"143","author":"Dvorak","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2019.09.002","article-title":"Functional flow cytometry of monocytes for routine diagnosis of innate primary immunodeficiencies","volume":"145","author":"Ammann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib5","doi-asserted-by":"crossref","unstructured":"Baxter SK, Walsh T, Casadei S, Eckert MM, Allenspach EJ, Hagin D, et\u00a0al. Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management [published online ahead of print April 20, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.005.","DOI":"10.1016\/j.jaci.2021.04.005"},{"key":"10.1016\/j.jaci.2021.10.010_bib6","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib7","doi-asserted-by":"crossref","unstructured":"Crowley TB, Campbell IM, Liebling EJ, Lambert MP, Levitt Katz LE, Heimall J, et\u00a0al. Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases [published online ahead of print June 16, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.06.007.","DOI":"10.1016\/j.jaci.2021.06.007"},{"key":"10.1016\/j.jaci.2021.10.010_bib8","doi-asserted-by":"crossref","unstructured":"Gro\u00df M, Speckmann C, May A, Gajardo-Carrasco T, Wustrau K, Maier SL, et\u00a0al. Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity [published online ahead of print May 24, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.05.007.","DOI":"10.1016\/j.jaci.2021.05.007"},{"key":"10.1016\/j.jaci.2021.10.010_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10875-021-00980-1","article-title":"The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS Committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib10","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jaci.2020.01.014","article-title":"Severe combined immunodeficiency caused by inositol-trisphosphate 3-kinase B (ITPKB) deficiency","volume":"145","author":"Almutairi","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood.2020008629","article-title":"SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation","volume":"138","author":"Delmonte","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.10.010_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2019.05.003","article-title":"Combined immunodeficiency in a patient with c-Rel deficiency","volume":"144","author":"Beaussant-Cohen","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib13","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jaci.2019.02.014","article-title":"F-BAR domain only protein 1 (FCHO1) deficiency is a novel cause of combined immune deficiency in human subjects","volume":"143","author":"Calzoni","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2019.03.002","article-title":"Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency","volume":"144","author":"Alosaimi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2019.02.019","article-title":"Impaired control of multiple viral infections in a family with complete IRF9 deficiency","volume":"144","author":"Bravo Garc\u00eda-Morato","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaci.2020.12.656","article-title":"Loss of DIAPH1 causes SCBMS, combined immunodeficiency, and mitochondrial dysfunction","volume":"148","author":"Kaustio","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2019.10.004","article-title":"Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1","volume":"145","author":"Cui","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10875-020-00903-6","article-title":"POLD1 deficiency reveals a role for POLD1 in DNA repair and T and B cell development","volume":"41","author":"Nichols-Vinueza","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib19","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1172\/JCI128903","article-title":"Polymerase delta deficiency causes syndromic immunodeficiency with replicative stress","volume":"129","author":"Conde","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2021.10.010_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaci.2019.09.020","article-title":"Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome","volume":"145","author":"Bernstock","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaci.2019.11.016","article-title":"Defining a new immune deficiency syndrome: MAN2B2-CDG","volume":"145","author":"Verheijen","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2020.06.007","article-title":"Heterozygous IKK\u03b2 activation loop mutation results in a complex immunodeficiency syndrome","volume":"147","author":"Abbott","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib23","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1084\/jem.20180639","article-title":"Gain-of-function IKBKB mutation causes human combined immune deficiency","volume":"215","author":"Cardinez","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.10.010_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaci.2020.08.040","article-title":"Combined immunodeficiency caused by a novel homozygous NFKB1 mutation","volume":"147","author":"Mandola","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2021.03.045","article-title":"Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency","volume":"148","author":"Vavassori","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jaci.2019.06.003","article-title":"Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy","volume":"144","author":"G\u00f6\u00f6s","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib27","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jaci.2020.03.034","article-title":"Defective Sec61\u03b11 underlies a novel cause of autosomal dominant severe congenital neutropenia","volume":"146","author":"Van Nieuwenhove","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jaci.2019.07.038","article-title":"Recurrent inflammatory disease caused by a heterozygous mutation in CD48","volume":"144","author":"Volkmer","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaci.2021.02.044","article-title":"Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome","volume":"148","author":"Chen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2019.11.015","article-title":"Defining the biological responses of IL-6 by the study of a novel IL-6 receptor chain immunodeficiency","volume":"145","author":"Nahum","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib31","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.10.010_bib32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jaci.2018.12.987","article-title":"Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients","volume":"143","author":"Ben-Ali","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2020.12.629","article-title":"Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency","volume":"148","author":"Shafer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib34","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2020.06.032","article-title":"A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI)","volume":"146","author":"Lin","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib35","doi-asserted-by":"crossref","unstructured":"Lu HY, Sharma M, Sharma AA, Lacson A, Szpurko A, Luider J, et\u00a0al. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency [published online ahead of print September 30, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.006.","DOI":"10.1016\/j.jaci.2021.04.006"},{"key":"10.1016\/j.jaci.2021.10.010_bib36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2019.01.033","article-title":"Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells","volume":"144","author":"Bier","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib38","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191336","article-title":"Activated PI3K\u03b4 breaches multiple B cell tolerance checkpoints and causes autoantibody production","volume":"217","author":"Lau","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.10.010_bib39","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jaci.2019.01.001","article-title":"A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency","volume":"143","author":"Lougaris","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib40","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2018.04.027","article-title":"Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype","volume":"143","author":"Tirosh","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jaci.2020.04.005","article-title":"Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome","volume":"146","author":"Rigoni","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaci.2019.09.026","article-title":"Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes","volume":"145","author":"Wen","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaci.2019.09.016","article-title":"Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function","volume":"145","author":"Vargas-Hern\u00e1ndez","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib44","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaci.2020.09.005","article-title":"It\u2019s that time of year\u2014APRIL promotes humoral immunity in humans","volume":"146","author":"Tangye","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib45","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jaci.2020.03.025","article-title":"APRIL-dependent lifelong plasmacyte maintenance and immunoglobulin production in humans","volume":"146","author":"Yeh","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib46","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jaci.2021.01.027","article-title":"Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1","volume":"147","author":"Kury","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaci.2019.12.004","article-title":"Hypomorphic\u00a0variants in AK2 reveal the contribution of mitochondrial function to B-cell activation","volume":"146","author":"Chou","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaci.2019.11.051","article-title":"Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"146","author":"Lorenzini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210566","article-title":"Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency","volume":"218","author":"Li","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.10.010_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2020.03.001","article-title":"Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality","volume":"146","author":"Lougaris","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.612323","article-title":"Clinical and genetic profile of X-linked agammaglobulinemia: a multicenter experience from India","volume":"11","author":"Rawat","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib54","doi-asserted-by":"crossref","unstructured":"Abyazi ML, Bell KA, Gyimesi G, Baker TS, Byun M, Ko HM, et\u00a0al. Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications [published online ahead of print September 30, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.06.008.","DOI":"10.1016\/j.jaci.2021.06.008"},{"key":"10.1016\/j.jaci.2021.10.010_bib55","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jaci.2020.02.025","article-title":"Exhausted phenotype of follicular CD8 T cells in CVID","volume":"146","author":"Klocperk","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.01.046","article-title":"Plasma protein profiling reflects TH1-driven immune dysregulation in common variable immunodeficiency","volume":"146","author":"Hultberg","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib57","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2019.08.007","article-title":"Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage","volume":"144","author":"Le Coz","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaci.2018.06.012","article-title":"Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses","volume":"143","author":"Romberg","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib59","doi-asserted-by":"crossref","unstructured":"Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, et\u00a0al. Therapeutic options for CTLA-4 insufficiency [published online ahead of print September 30, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.039.","DOI":"10.1016\/j.jaci.2021.04.039"},{"key":"10.1016\/j.jaci.2021.10.010_bib60","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score","volume":"145","author":"Tesch","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaci.2018.04.032","article-title":"Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase \u03b4 syndrome type 1","volume":"143","author":"Okano","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib62","doi-asserted-by":"crossref","unstructured":"Dimitrova D, Nademi Z, Maccari ME, Ehl S, Uzel G, Tomoda T, et\u00a0al. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome [published online ahead of print September 30, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.036.","DOI":"10.1016\/j.jaci.2021.04.036"},{"key":"10.1016\/j.jaci.2021.10.010_bib63","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jaci.2020.08.034","article-title":"Long-term outcomes for adults with chronic granulomatous disease in the United Kingdom","volume":"147","author":"Campos","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib64","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2019.04.014","article-title":"Tamoxifen restores extracellular trap formation in neutrophils from patients with chronic granulomatous disease in a reactive oxygen species-independent manner","volume":"144","author":"Sharma","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib65","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.jaci.2019.01.046","article-title":"Lymphoproliferative disease in patients with Wiskott-Aldrich syndrome: analysis of the French Registry of Primary Immunodeficiencies","volume":"143","author":"Cheminant","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib66","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jaci.2018.12.1010","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT\/ESID-IEWP-SCETIDE-PIDTC study","volume":"143","author":"Ferrua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib67","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.jaci.2018.12.1013","article-title":"Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome","volume":"143","author":"Bucciol","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib68","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jaci.2019.02.003","article-title":"A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency","volume":"143","author":"Volpi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib69","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1182\/blood.2020006738","article-title":"Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency","volume":"136","author":"Ghosh","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.10.010_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2019.03.025","article-title":"Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1\/IKAROS mutations","volume":"144","author":"Kellner","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2020.04.053","article-title":"Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency","volume":"146","author":"Lum","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib72","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jaci.2018.11.027","article-title":"Late thymic deficiency after HLA-haploidentical hematopoietic stem cell transplantation for severe combined immunodeficiency","volume":"143","author":"Ege","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib73","doi-asserted-by":"crossref","unstructured":"Delmonte OM, Castagnoli R, Yu J, Dvorak CC, Cowan MJ, D\u00e1vila Salda\u00f1a BJ, et\u00a0al. Poor T-cell receptor \u03b2 repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution [published online ahead of print September 30, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.07.029.","DOI":"10.1016\/j.jaci.2021.07.029"},{"key":"10.1016\/j.jaci.2021.10.010_bib74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2019.01.030","article-title":"New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies","volume":"144","author":"Elfeky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2020.03.043","article-title":"HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency","volume":"146","author":"Prunotto","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib76","doi-asserted-by":"crossref","unstructured":"Marsh RA, Hebert K, Kim S, Dvorak CC, Aquino VM, Baker KS, et\u00a0al. Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders [published online ahead of print September 30, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.07.031.","DOI":"10.1016\/j.jaci.2021.07.031"},{"key":"10.1016\/j.jaci.2021.10.010_bib77","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s10875-021-00966-z","article-title":"Hematopoietic cell transplantation with reduced intensity conditioning using fludarabine\/busulfan or fludarabine\/melphalan for primary immunodeficiency diseases","volume":"41","author":"Nishimura","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib78","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2020.04.033","article-title":"Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency","volume":"147","author":"Castiello","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib79","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib80","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex\u00a0vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.10.010_bib81","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.10.010_bib82","doi-asserted-by":"crossref","unstructured":"Markert ML, Gupton SE, McCarthy EA. Experience with cultured thymus tissue in 105 children [published online ahead of print September 30, 2021]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.06.028.","DOI":"10.1016\/j.jaci.2021.06.028"},{"key":"10.1016\/j.jaci.2021.10.010_bib83","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2019.08.029","article-title":"Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells","volume":"145","author":"Pouzolles","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib84","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: an international study","volume":"147","author":"Meyts","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib85","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s10875-021-01066-8","article-title":"Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study","volume":"41","author":"Goudouris","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib86","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","article-title":"COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience","volume":"147","author":"Shields","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib87","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s10875-021-01046-y","article-title":"Robust antibody and T cell responses to SARS-CoV-2 in patients with antibody deficiency","volume":"41","author":"Kinoshita","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.10.010_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib91","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","article-title":"Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis","volume":"148","author":"Lemarquis","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.10.010_bib92","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity","volume":"148","author":"Hagin","year":"2021","journal-title":"J Allergy Clin Immunol"}],"updated-by":[{"DOI":"10.1016\/j.jaci.2022.05.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000}}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921016213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921016213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T23:13:17Z","timestamp":1656717197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921016213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0091674921016213"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.10.010","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jaci.2022.05.005","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inborn errors of immunity: Recent progress","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}